Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes

Diabetes Research and Clinical Practice

Volumn 90, Issue 3, 2010, Pages

  Chimenti, Elisa Moya ^a   de la Morena, Lucrecia Herranz ^b   Vaquero, Pilar Martín ^b   Sáez de ibarra, Lourdes ^b   Domínguez, María García ^c   Sánchez, Luis Felipe Pallardo ^b  

^a HOSPITAL INFANTA CRISTINA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c Hospital Universitario del Sureste de Madrid   (Spain)

Author keywords

Continuous subcutaneous insulin infusion (CSII); Diabetes mellitus Type 1 (T1DM); Glycaemic control

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; ELECTRONIC SENSOR; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; INFUSIONS, SUBCUTANEOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MONITORING, AMBULATORY;

EID: 78649472352     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.08.016     Document Type: Article

References (10)

1. Pickup J., Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diab Care 2002, 25:593-598.
2. Alemzadeh R., Loppnow C., Parton E., Kirby M. Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. Diab Technol Ther 2003, 5:167-173.
3. Golicki D.T., Golicka D., Groele L., Pankowska E. Continuous glucose monitoring system in children with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 2008, 51:233-240.
4. Mastrototaro J. The MiniMed continuous glucose monitoring system (CGMS). J Pediatr Endocrinol Metab 1999, 12:751-758.
5. Heptulla R.A., Allen H.F., Gross T.M., Reiter E.O. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy. Pediatr Diab 2004, 5:10-15.
6. Deiss D., Hartmann R., Hoeffe J., Kordonouri O. Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapy. Pediatr Diab 2004, 5:117-121.
7. Lagarde W.H., Barrows F.P., Davenport M.L., Kang M., Guess H.A., Calikoglu A.S. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diab 2006, 7:159-164.
8. Bruttomeso D., Crazzolara D., Maran A., Costa S., Dal Pos M., Girelli A., et al. In type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diab Med 2008, 25:326-332.
9. Salardi S., Zucchini S., Santoni R., Ragni L., Gualandi S., Cicognani A., et al. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(1c) in pediatic type 1 diabetic patients. Diab Care 2002, 25:1840-1844.
10. Renard E., Schaepelynk-Bélicar P. Implantable insulin pumps: a position statement about their clinical use. Diab Metab 2007, 33:158-166. EVADIAC Group.